Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (9)
  • Chk
    (6)
  • HSP
    (6)
  • Autophagy
    (4)
  • Bcl-2 Family
    (4)
  • Wnt/beta-catenin
    (4)
  • Akt
    (3)
  • Aurora Kinase
    (3)
  • CDK
    (3)
  • Others
    (18)
Filter
Search Result
Results for "

cct-β

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    53
    TargetMol | All_Pathways
  • Peptide Products
    1
    TargetMol | Peptide_Products
  • Dye Reagents
    2
    TargetMol | All_Dye_Reagents
  • PROTAC Products
    3
    TargetMol | PROTAC
  • Natural Products
    1
    TargetMol | Natural_Products
  • Recombinant Protein
    2
    TargetMol | Recombinant_Protein
  • Antibody Products
    1
    TargetMol | Antibody_Products
  • Cell Research
    1
    TargetMol | Cell_Research_Reagents
CCT 031374 hydrobromide
T216851219184-91-4In house
CCT 031374 hydrobromide is a TCF/β-catenin inhibitor with antitumor activities.
  • $32
In Stock
Size
QTY
CCT241533
T107181262849-73-9In house
CCT241533 is an effective and selective ATP competitive inhibitor of CHK2 (Ki: 1.16 nM; IC50: 3 nM).
  • $1,520
1-2 weeks
Size
QTY
CCT-251921
T149011607837-31-9In house
CCT-251921 is a potent, selective, and orally bioavailable CDK8 inhibitor [IC50: 2.3 nM].
  • $87
In Stock
Size
QTY
CCT020312
T14902324759-76-4In house
CCT020312 (0-9 µM, 24 h) treatment of medium HT29 cells for 24 h resulted in a concentration-dependent loss of P-S608-pRB signaling with linear response values between 1.8 and 6.1 µM.
  • $56
In Stock
Size
QTY
CCT367766
T149082229856-58-8In house
CCT367766 is a potent, PROTAC-based, third-generation, iso-functional pirin-targeted protein degradation probe (PDP) that depletes pirin expression at low concentrations.CCT367766 has an IC50 value of 490 nM for the CRBN-DDB1 complex.CCT367766 has a good affinity for recombinant pirin and CRBN. CCT367766 has a good affinity for recombinant pirin and CRBN, with Kd values of 55 nM and 120 nM, respectively. cct367766 is a potent orally active protein that reduces the expression of pirin at low concentrations.
  • $293
In Stock
Size
QTY
CCT077791
CCT-077791, CCT 077791
T25215748777-47-1In house
CCT077791 is a potent inhibitor of p300 and PCAF histone acetyltransferase activity for cancer research.
  • $1,520
6-8 weeks
Size
QTY
CCT365623
CCT-365623, CCT 365623
T269692126134-01-6In house
CCT365623 is an orally bioavailable Lysyl Oxidase inhibitor with good anti-LOX potency, selectivity, pharmacokinetic properties, as well as anti-metastatic efficacy.
  • $83
In Stock
Size
QTY
rac-CCT-250863 HCl
rac-CCT-250863 HCl(1364269-06-6 Free base)
T28498LIn house
rac-CCT-250863 HCl is a selective and reversible inhibitor of NEK 2. rac-CCT-250863 HCl induces cell cycle arrest and has good anti-proliferative activity against cancer cells. rac-CCT-250863 HCl can be used in combination with Pomalidomide to induce apoptosis and can be used in combined anti-cancer studies.
  • $552
In Stock
Size
QTY
CCT241161
T96381163719-91-2In house
CCT241161 is an orally active pan-RAF inhibitor, with IC50 values of 3, 6, 10, 15, and 30 nM for LCK, CRAF, SRC, V600E-BRAF, and BRAF, respectively. It exhibits significant activity against BRAF and NRAS mutant melanomas and demonstrates anticancer cell proliferative effects [1].
  • $139
In Stock
Size
QTY
CDK8/19-IN-51
CCT251545 analogue, Compound 51
T226331860885-61-5
CDK8/19-IN-51 is an orally active and highly effective dual inhibitor of CDK8 and CDK19, with anticancer activity. Its IC50 values for CDK8 and CDK19 are 5.1 nM and 5.6 nM, respectively. It is used in studies of colorectal and gastric cancers.
  • $530
In Stock
Size
QTY
CCT251545
T149071661839-45-7
CCT251545 is an potent and oral-bioavailable WNT signaling inhibitor(IC50 of 5 nM in 7dF3 cells).
  • $35
In Stock
Size
QTY
TargetMol | Citations Cited
CCT241533 hydrochloride
T10718L1431697-96-9
CCT241533 hydrochloride is an effective and selective ATP competitive inhibitor of CHK2 (Ki: 1.16 nM; IC50: 3 nM).
  • $67
In Stock
Size
QTY
CCT365623 hydrochloride
T107192126136-98-7
CCT365623 hydrochloride is an orally active lysyl oxidase (LOX) inhibitor with an IC50 of 0.89 μM and suppresses EGFR (pY1068) and AKT phosphorylation induced by EGF.
  • $1,820
1-2 weeks
Size
QTY
CCT129957
T14903883098-58-6
CCT129957 is a novel and potent phospholipase C-γ (PLC-γ) inhibitor with an IC50 of about 3 μM and a GC50 of 15 μM.CCT129957 exhibits anticancer activity and inhibits Ca2+ release in squamous cells.
  • $39
In Stock
Size
QTY
CCT244747
CCT 244747
T149041404095-34-6
CCT244747 is a potent and highly selective CHK1 inhibitor that is orally active, ATP-competitive, and cytotoxic, abrogating drug-induced S and G2 blockade and inducing apoptosis in multiple tumor cell lines.
  • $69
In Stock
Size
QTY
CCT251236
T149051693731-40-6
CCT251236 is a cell-based phenotypic high-throughput screening (HTS) chemical probe developed to screen for inhibitors of the HSF1 stress pathway.CCT251236 exhibits antimyeloma activity and inhibits HSF1.
  • $31
In Stock
Size
QTY
CCT251455
CCT 251455
T149061400284-80-1
CCT251455, the mitotic kinase monopolar spindle 1 (MPS1/TTK) inhibitor, is a potent (IC50=3 nM) and specific chemical tool.
  • $1,820
In Stock
Size
QTY
CCT007093
T1927176957-55-4
CCT007093 is an effective PPM1D (WIP1) inhibitor (IC50: 8.4 μM).
  • $39
In Stock
Size
QTY
TargetMol | Citations Cited
CCT018159
T21872171009-07-7
CCT018159 is a 3,4-diarylpyrazole resorcinol, an ATP-competitive HSP90ATPase inhibitor that inhibits human Hsp90β and yeast Hsp90 with IC50s of 3.2 and 6.6 μM, respectively.CCT018159 inhibits key endothelial and tumor cell functions associated with invasion and angiogenesis. CCT018159 caused cellular inhibition associated with G1 phase block and induced apoptosis.
  • $31
In Stock
Size
QTY
VER49009
VER-49009, VER 49009, CCT0129397
T2268940289-57-6
VER49009 (CCT0129397) is an effective HSP90 inhibitor(IC50 =25 nM, Kd=78 nM).
  • $55
In Stock
Size
QTY
CCT-271850
MPS1-IN-77, MPS1IN77, MPS1 IN 77, CCT271850, CCT 271850
T238651578244-34-4
CCT-271850 is an inhibitor of the spindle checkpoint function of Monospindle 1.
  • $1,820
8-10 weeks
Size
QTY
CCT 137690
CCT137690
T26111095382-05-0
CCT 137690 is a highly specific and oral-available aurora kinase inhibitor, for aurora A(IC50=15 nM ), B(IC50=25 nM) and C(IC50=19 nM).
  • $35
In Stock
Size
QTY
rac-CCT-250863
T284981364269-06-6
Rac-CCT-250863, a potent Nek2 inhibitor, exhibits selectivity for Nek2 over PLK1, MPS1, Cdk2 and Aurora A.
  • $1,420
35 days
Size
QTY
VER-49009
CCT 129397
T3454558640-51-0
VER-49009 (CCT 129397) is a potent Hsp90 inhibitor(IC50 of 25 nM and Kd of 78 nM).
  • $38
In Stock
Size
QTY